Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 22.66

+2.5%

Jan 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robin who wrote (4759)	11/4/1998 7:56:00 AM
From: JanyBlueEyes	Read Replies (1) of 5736

CCSI vs SpectRx - a non-issue SPECTRX'S DEVICE DOES NOT WORK ON AN INFANT THAT UNDERGOES PHOTOTHERAPY TREATMENT. Phototherapy (baby is put under special lights to bring down the level of bilirubin) is a routine treatment given to a baby if/when the level of bilirubin in the blood reaches a certain level (determined by the physician). Every hospital uses these lights. An infant's skin changes during and after going under the lights (redness and/or tanning can occur) and the Spectrx device is UNABLE to make an accurate reading. Chromatics' device has been tested and does make accurate readings during the phototherapy treatment and after. Unlike the SpectRx device, it can be used the entire time monitoring for elevated bilirubin levels is needed. Simply put: The physicians want the device that works.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next